Clinical Trial Tests Nivolumab for Patients with Rare Brain and Spine Cancers

This phase 2 clinical trial, led by Dr. Marta Penas-Prado, is for adults (age 18 or above) with rare brain and spine tumors. The goal is to test whether stimulating the immune system using the drug nivolumab can shrink these tumors or increase the time it takes for them to grow or spread. Questions? Contact the NCI Neuro-Oncology Branch at (240) 760-6010 or NCINOBReferrals@mail.nih.gov. Learn more about the trial: https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2018-03485 Watch this video with audio descriptions: https://youtu.be/GBGFYIBErL4

Video Lainnya